A study of susceptibility-weighted imaging in patients with Wilson disease during the treatment of metal chelator

ConclusionsTherapy with DMPS and DMSA improves neurological symptoms of WD patients more quickly and leads to less aggravation, compared with therapy with DPA. The metal content in the brain of WD patients was at a low level after 3  years of treatment. DMPS and DMSA can remove metal from brain tissue faster than DPA.
Source: Journal of Neurology - Category: Neurology Source Type: research